Clover Health Ups Full-Year Guidance

 Total Revenue growth for the Second Quarter of 2024 of 11% year-over-year

GAAP Net Income from Continuing Operations during the Second Quarter of 2024 of $7.2 million versus Second Quarter 2023 GAAP loss of $28.9 million

Adjusted EBITDA profitability for the Second Quarter of 2024 of $36.2 million versus Second Quarter 2023 Adjusted EBITDA of $9.9 million

Increases Full-Year 2024 guidance to Insurance Revenue of $1.35 billion - $1.375 billion and Adjusted EBITDA profitability of $50 million - $65 million

https://www.globenewswire.com/news-release/2024/08/05/2924608/0/en/Clover-Health-Reports-Second-Quarter-2024-Financial-Results-Improves-Full-Year-Guidance-on-Strong-Performance.html